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Abstract
Medically unexplained oropharyngeal dysphagia (MUNOD) is a rare condition. It presents without demonstrable abnor-
malities in the anatomy of the upper aero-digestive tract and/or swallowing physiology. This study investigates whether
MUNOD is related to affective or other psychiatric conditions. The study included patients with dysphagic complaints who
had no detectible structural or physiological abnormalities upon swallowing examination. Patients with any underlying
disease or disorder that could explain the oropharyngeal dysphagia were excluded. All patients underwent a standardized
examination protocol, with FEES examination, the Hospital Anxiety and Depression Scale (HADS), and the Dysphagia
Severity Scale (DSS). Two blinded judges scored five different FEES variables. None of the 14 patients included in this
study showed any structural or physiological abnormalities during FEES examination. However, the majority did show
abnormal piecemeal deglutition, which could be a symptom of MUNOD. Six patients (42.8%) had clinically relevant
symptoms of anxiety and/or depression. The DSS scores did not differ significantly between patients with and without
affective symptoms. Affective symptoms are common in patients with MUNOD, and their psychiatric conditions could
possibly be related to their swallowing problems.
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Introduction
Patients with swallowing problems are commonly seen at
the otorhinolaryngology outpatient clinic. Their oropha-
ryngeal dysphagia (OD) may be attributed to somatic eti-
ologies such as head and neck cancer, progressive
neurological disorders, or stroke [1–3]. These disorders
may change the normal anatomy and/or disturb normal
function of the upper aero-digestive tract and thereby
hamper normal swallowing. Rarely, OD occurs without
demonstrable abnormalities in the anatomy of the upper
aero-digestive tract and/or swallowing physiology,
prompting a diagnosis of medically unexplained oropha-
ryngeal dysphagia (MUNOD) [4]. In the literature, this
condition is known by various names: functional dyspha-
gia, swallowing phobia, psychogenic dysphagia, or
phagophobia [4]. A functional somatic disorder is defined
as physical complaints or symptoms impairing normal
function of the bodily process that are not attributable to an
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underlying structural disease [5]. Functional somatic dis-
orders and comorbid anxiety and depression are both
associated with increased severity of symptoms and greater
illness burden [6]. Medical specialties tend to apply their
own diagnostic labels to functional somatic disorders.
Psychiatry uses the term somatic symptom disorder, while
other specialties make their own specific diagnosis (e.g.,
irritable bowel syndrome (IBS), fibromyalgia (FM), func-
tional dyspepsia (FD)) [5, 7]. In the field of mental health,
patients with MUNOD are frequently diagnosed with a
functional somatic disorder or rarely with phagophobia
(fear of swallowing). According to the DSM-V classifica-
tion, phagophobia belongs to the category of ‘specific
phobias’ [7], whereby exposure to the phobic stimulus
provokes an immediate anxiety response. The phobic sit-
uation is avoided or endured with intense distress. Also, the
specific phobia interferes with a patient’s normal routine,
functioning, or social activities. Phagophobia can only be
diagnosed if other psychiatric or somatic conditions are
excluded as a possible cause for the dysphagia and
accompanying emotional and bodily distress [7]. Patients
with phagophobia experience an abnormal sensation during
swallowing, sometimes accompanied by behavioral
abnormalities during swallowing examination [7]. In the
literature, phagophobia is often described in children [8, 9],
but little is known about this condition in adults. Given the
strong association of medically unexplained symptoms
with affective conditions, it is advisable to use the broader
term ‘MUNOD’ (instead of ‘phagophobia’). It may be a
symptom within other psychiatric conditions like obses-
sive-compulsive disorder, panic disorder, post-traumatic
stress disorder (PTSD), social phobia, or depression [10].
In patients with persistent complaints of MUNOD who do
not show detectible abnormalities upon swallowing
examination performed with fiberoptic endoscopic evalu-
ation of swallowing (FEES) or videofluoroscopic swal-
lowing study (VFSS), and who do not present with an
underlying somatic disease, a possible cause of the com-
plaints should be sought in a psychiatric condition (e.g.,
somatic symptom disorder, phagophobia, affective disor-
der, PTSD) [3, 4, 11, 12]. In most complex and high-uti-
lizing patients with OD, affective or somatoform
comorbidity should therefore be considered [13, 14].
Aim
So far, no other studies have investigated whether patients
with MUNOD have clinically relevant symptoms of anxi-
ety and depression. This study is the first to inquire whether
MUNOD is related to an affective condition or presents as
a symptom within another psychiatric condition. The aim
of this study is to better understand the psychiatric symp-
toms in patients with MUNOD and to provide guidance for
integrated (otorhinolaryngological and psychiatric) man-
agement strategies in the context of best clinical practice.
Materials and Methods
Patients
Patients with OD complaints (usually choking) who were
referred to the outpatient clinic for dysphagia of the
Maastricht University Medical Center (MUMC?) between
July 2011 and April 2016, without detectible abnormalities
in swallowing examination, were included in the study.
The following exclusion criteria were applied: age younger
than 18, age older than 85 (presbyphagia), complaints of
esophageal dysphagia (e.g., swallowing-related chest pain,
esophageal regurgitation, history of esophageal dysphagia),
history of head and neck cancer, evidence or suspicion of
neurodegenerative disease (e.g., Myasthenia Gravis, mul-
tiple sclerosis, Parkinson’s disease), stroke patients,
patients with a Zenker’s diverticulum or cervical spine
abnormalities, patients with any other somatic disease or
disorder that could explain the OD complaints, a score
below 23 on the Mini Mental State Examination (MMSE)
[15], or not knowing the Dutch language. Informed consent
was obtained from all patients.
Examination Protocol
All patients underwent a standardized examination proto-
col (prospectively collected data) used in daily clinical
practice at the outpatient clinic for dysphagia. This proto-
col comprises a structured interview, standardized otorhi-
nolaryngology examination, a standardized FEES
examination [16], the Hospital Anxiety and Depression
Scale (HADS) [17], a dysphagia severity scale (DSS)
[14, 18], Body Mass Index (BMI) measurement, and the
MMSE [15]. The FEES-examinations were carried out by
an experienced laryngologist together with the speech
therapist. First, patients had to perform three swallows of
10 cc thin liquid (water), then three swallows of 10 cc
standardized applesauce (One 2 fruit) (hereafter ‘thick
liquid’), and then one bite-sized cracker (80 gr Delhaize
Mini Toast). All liquids were dyed with 5% methylene
blue (10 mg/ml). A flexible fiberoptic endoscope, Pentax
FNL-10RP3 (Pentax Canada Inc., Mississauga, Ontario,
Canada), was used during the FEES examination. The tip
of the endoscope was in ‘high position,’ just above the
epiglottis, so the scope could not interfere with closure of
the laryngeal vestibule [16]. The FEES videos were
obtained with the Xion SD camera, Xion EndoSTROBE
camera control unit (PAL 25 fps), and Matrix DS data
station with DIVAS software (Xion Medical, Berlin,
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Germany) and recorded on a DVD. Second, the investi-
gators administered the HADS, a validated tool to assess
clinically relevant symptoms of anxiety and/or depression.
It consists of 14 items: seven on the anxiety subscale and
seven on the depression subscale. Each single item is
scored from 0 to 3, resulting in a minimum of 0 and a
maximum of 21 points on each subscale. A higher score
indicates more anxiety or depression symptoms. A score of
C 8 on a subscale implies the presence of clinically rele-
vant anxiety or depression symptoms, which is an indicator
of an anxiety disorder or depression [17, 19, 20]. Third, a
patient’s subjective swallowing assessment was measured
with the DSS, a visual analog scale (VAS); this instrument
is a psychometric response scale for measuring subjective
characteristics or attitudes [14, 18]. Dysphagic patients
specify their level of agreement with a statement or ques-
tion by indicating a position along a continuous line
between two end-points for the DSS. The single question
was, ‘‘How do you rate your swallowing today?’’ A score
of 100 (maximum) indicates normal swallowing. The
MMSE is a tool to screen patient’s cognitive status. A score
below 23 is interpreted as mild cognitive impairment for
which a formal cognitive assessment to determine the
pattern and extent of deficits is recommended. Therefore,
to reduce possible bias in the HADS and DSS outcomes
due to cognitive dysfunctions in the present study, patients
with an MMSE below 23 were excluded.
FEES Variables
To be sure that none of the selected patients had severe
abnormalities during FEES examination (e.g., severe
pooling, deep penetration, aspiration), suggesting a possi-
ble underlying somatic cause, five visuoperceptual ordinal
variables (piecemeal deglutition, postswallow vallecular
pooling, postswallow pyriform sinus pooling, laryngeal
penetration, and aspiration) were scored by two indepen-
dent judges [13, 21–26]. All of these variables were scored
for every FEES swallow at varying speed. The judges
underwent consensus training for these measurements, as
described previously [13, 21–26]. Both judges were blin-
ded to the patients’ identity and medical history. The jud-
ges were also blinded to each other’s scores. To determine
intraobserver agreement, 30 (29%) of the FEES swallows
were rated twice (repeated measurements). These FEES
swallows were randomly selected and again blinded for
both judges. Fatigue-related observer bias was avoided by
limiting the judge’s rating task to two hours per session.
Statistical Analysis
Levels of interobserver and intraobserver agreement were
measured for each variable by the linear weighted kappa
coefficient. Results were expressed as the median (range)
for continuous variables, while frequencies and proportions
(%) were used for ordinal FEES variables. The Mann–
Whitney U test and the Chi-squared test were used for
group comparisons. Spearman’s rho was used for correla-
tions between continuous variables. All statistical analyses
were performed with IBM SPSS Statistics for Mac, version
22.0 (Armonk, NY: IBM Corp.).
Results
Participants
Approximately 120 patients per year visited the outpatient
clinic for dysphagia. Patients were referred by general
practitioners, otorhinolaryngologists, or other specialists
such as a neurologist or pulmonologist. The main reason
for referral was to exclude pathology of the upper aero-
digestive tract as a cause for OD. Fourteen patients met the
criteria for MUNOD and were included in the study. The
median age was 52 (19–68). In total seven of the partici-
pants (50%) were female. See Table 1 for general patients’
characteristics.
Observer Agreement
Table 2 shows levels of inter- and intraobserver agreement
for all FEES variables with 95% confidence interval.
Intraobserver agreement levels are shown for both raters
separately. All levels of agreement were almost perfect
(Kappa[ 0.9). The lowest level of interobserver agree-
ment was 0.95 (95% CI 0.89–1.00) for postswallow pyri-
form sinus pooling. The lowest level of intraobserver
agreement was 0.90 (95% CI 0.80–1.00) for postswallow
vallecular pooling. The prevalence of impairment was very
low for all variables.
FEES Variables
Descriptive data of the FEES variables are displayed in
Table 3. Piecemeal deglutition was rated as normal (cate-
gory 0) in 31.0% (N = 13), 16.7% (N = 7), and 7.1%
(N = 1) of the swallows for thin liquid consistency, thick
liquid consistency, and bite-sized cracker, respectively. In
five patients, postswallow vallecular pooling was rated as
mild (14.3 and 7.1% of the swallows for thin liquid and
thick liquid consistency, respectively), but in none of these
patients was pooling observed in all seven recorded swal-
lows. All five patients showed at least one normal swallow
without vallecular pooling. None of the swallows was rated
as severe vallecular pooling (category 2). Penetration was
observed in two patients. The first patient showed a trace of
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methylene blue on the laryngeal side of the epiglottis
during the first thin liquid swallow. The second patient
showed deeper penetration, near the vocal folds, in multi-
ple swallows and was therefore excluded because an
underlying somatic cause of OD could not be excluded.
None of the patients showed aspiration or pyriform sinus
pooling during the swallowing examination. The study
population was too small to perform further statistical
analyses.
Hads
Six of the 14 participants (42.8%) showed clinically rel-
evant symptoms of anxiety (score C 8 on the anxiety
subscale). Three of the 14 (21.4%) showed clinically
relevant symptoms of depression (score C 8 on the
depression subscale). These three also had a score C 8 on
the anxiety subscale. Thus, 42.8% (N = 6) of the partic-
ipants had clinically relevant symptoms of anxiety and/or
depression. The Chi-squared test showed no gender dif-
ferences between patients with and without clinically
relevant symptoms of anxiety (p = 0.28) or depression
(p = 0.51). The Mann–Whitney U test showed no age
differences between patients with and without clinically
relevant symptoms of anxiety (p = 1.00) or depression
(p = 0.76).
DSS
The median score for the DSS was 66.0 (18–100). Spear-
man’s rho revealed no significant correlation between age
and DSS. The DSS was not significantly different for
patients with clinically relevant symptoms of anxiety or
depression compared to patients without symptoms of
anxiety or depression. Males scored significant higher on
the DSS compared to females. See Table 4 for the results
of the Mann–Whitney U tests for group comparison.
Discussion
This is the first study that investigates swallowing function
in relation to symptoms of anxiety and depression in
patients with MUNOD. All 14 included patients presented
with complaints of OD, and none showed structural
abnormalities during FEES examination. However, the
majority showed abnormal piecemeal deglutition, which
could be an early symptom of an underlying somatic dis-
order impairing normal swallowing physiology. However,
it is conceivable that abnormal piecemeal deglutition is a
clinically relevant symptom of MUNOD. Since these
patients are often anxious about swallowing, multiple
swallows of smaller fragments of the same bolus may offer
them a sense of safety or control. In these patients,
Table 1 Patients’ characteristics
Subject Age Gender BMI MMSE-
score
Psychiatric history Psychiatric
medication
Referred by No. of visits
otorhinolaryngology
outpatient clinic MUMC?
1 56 Female 29 30 – – GP 6
2 27 Male 17 30 Pervasive developmental
disorder—not otherwise
specified
– Internist 1
3 43 Male 17 25 Cluster B personality
disorder
Temazepam,
Oxazepam
GP 2
4 41 Female 21 23 Panic disorder Citalopram Otorhinolaryngologist 3
5 51 Male 23 30 – – MV 1
6 68 Male 25 29 – – GP 1
7 26 Male MV 23 – – GP 9
8 53 Male MV 23 – – Otorhinolaryngologist 3
9 63 Female MV 26 – – GP 1
10 19 Female 16 23 – – GP 1
11 60 Female 37 29 Psychotic depression Quetiapine Neurologist 1
12 61 Female 34 29 – – Internist 1
13 34 Female 20 30 – – GP 2
14 66 Male 25 30 – – Pulmonologist 2
BMI Body Mass Index, MMSE mini mental state examination, GP general practitioner, MV missing value, MUMC? Maastricht University
Medical Center
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piecemeal deglutition seems to be a habitual coping strat-
egy rather than a subclinical neurogenic impaired swal-
lowing pattern. Nevertheless, follow-up for a possible
progressive neurologic disease is recommended. It is
assumed that swallowing physiology in patients with
MUNOD is normal. However, an interesting question is
whether MUNOD could disturb normal swallowing phys-
iology. Roland et al. evaluated the incidence of esophageal
contractility disturbances in psychiatric patients [27].
Manometry showed a high percentage of functional motor
impairment in patients with complaints of anxiety and/or
depression, while endoscopy in these patients showed no
structural abnormalities [27]. In a large prospective popu-
lation-based study, Koloski et al. showed that anxiety is an
independent predictor for new onset functional gastroin-
testinal disorders like irritable bowel syndrome, suggesting
that affective disorders can underlie physical symptoms
[28]. The bladder–gut–brain axis is an interesting frame-
work. It suggests a bidirectional pathway between brain
and body, assuming that both functional and affective
disorders are stress related and that functional symptoms
are a sensitized response to earlier threats. This sensitiza-
tion might mediate false-alarm signals (alarm falsification
as a defense system). That, in turn, could provoke emo-
tional and physical distress, resulting in psychiatric con-
ditions and functional disorders like MUNOD [6, 28]. A
study by Dum et al. raised the possibility that motor areas
of the cerebral cortex are important in the stress and
depression connectome [29], and Grillon et al. suggested
that anxiety increases motor response inhibition [30].
These studies indicate a relationship between affective
function and motor function and thus strengthen the
assumption that functional complaints might be part of a
hypersensitivity or alarm-falsification disorder [6]. By
Table 2 Interobserver and intraobserver agreement levels per FEES variable assessed with linear weighted Kappa and 95% confidence interval
FEES outcome
variable
Definition Ordinal scalea Interobserver
agreement (95%
CI)
Intraobserver agreement (95% CI)
Observer 1 Observer 2
Piecemeal
deglutition
Sequential swallowing on the
same bolus
Five-point scale (0–4)
0 = no additional swallows
1 = one additional swallow
2 = two additional
swallows
3 = three additional
swallows
4 = four additional
swallows
0.99b (0.97–1.00) 0.93 (0.84–1.00) 0.93 (0.84–1.00)
Postswallow
vallecular
pooling
Pooling in valleculae after the
swallow
Three-point scale (0–2)
0 = no pooling
1 = filling of less than 50%
of the valleculae
2 = filling of more than
50% of the valleculae
0.95 (0.91–1.00) 0.96 (0.89–1.00) 0.90 (0.80–1.00)
Postswallow
pyriform sinus
pooling
Pooling in pyriform sinuses after
the swallow
Three-point scale (0–2)
0 = no pooling
1 = trace to moderate
pooling
2 = severe pooling up to
complete filling of the
sinuses
0.95 (0.89–1.00) 1.00 1.00
Penetration and
aspiration
Penetration of bolus in the
laryngeal vestibule, above the
vocal folds
Aspiration of bolus below the
vocal folds
Three-point scale (0–2)
0 = no penetration
1 = penetration
2= aspiration
0.98 (0.96–1.00) 0.97 (0.90–1.00) 0.97 (0.90–1.00)
Results of intraobserver agreement are given for both observers
aLower scores refer to normal functioning, whereas higher scores refer to more severe disability
bKappa values:\ 0 = less than chance agreement; 1 = perfect agreement
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implication, MUNOD and functional motor impairment
may be interrelated too, causing disturbances of the normal
swallowing physiology (such as increased piecemeal
deglutition). So far, no studies have been published on this
subject. However, the assumption that patients with
MUNOD must have a normal swallowing function might
be incorrect. Through this bidirectional pathway, a psy-
chiatric problem can have sensorimotor effects on the
swallowing function without there being any other cause of
dysphagia, such as a chronic neurological disorder. Then, it
would be plausible that OD can be caused by affective
disorders or psychiatric conditions, even when the swal-
lowing physiology is disturbed. In this study, none of the
participants had symptoms indicating an underlying
somatic disease, and none showed other abnormalities
during structured interviews or general otorhinolaryngol-
ogy examination (normal cranial nerve integrity, speech,
etc.). Although a somatic cause of dysphagia might seem
unlikely, MUNOD should always be a diagnosis of
exclusion.
Previous research showed a high prevalence of clinically
relevant affective symptoms in OD patients [13, 14, 31].
The present study underpins these data. It also shows a high
prevalence (42.8%) of clinically relevant affective symp-
toms, which indicates that MUNOD seems to be related to
Table 3 Frequency distribution
of swallows per category of the
different FEES variables, given
as absolute numbers (N) and
percentages (%)
FEES category frequencies
Thin liquid consistency
N (%)
N = 42
Thick liquid consistency
N (%)
N = 42
Bite-sized cracker
N (%)
N = 14
Piecemeal deglutition
Category 0 13 (31.0) 7 (16.7) 1 (7.1)
Category 1 10 (23.8) 15 (35.7) 2 (14.3)
Category 2 13 (30.9) 10 (23.8) 2 (14.3)
Category 3 1 (2.4) 3 (7.1) 2 (14.3)
Category 4 5 (11.9) 6 (14.3) 6 (42.9)
MVa 0 1 (2.4) 1 (7.1)
Postswallow vallecular pooling
Category 0 35 (83.3) 36 (85.7) 12 (85.7)
Category 1 6 (14.3) 3 (7.1) 0
Category 2 0 0 0
MV 1 (2.4) 3 (7.1) 2 (14.3)
Postswallow pyriform sinus pooling
Category 0 41 (97.6) 40 (95.2) 12 (85.7)
Category 1 0 0 0
Category 2 0 0 0
MV 1(2.4) 2 (4.8) 2 (14.3)
Penetration/aspiration
Category 0 40 (95.2) 41 (97.6) 12 (85.7)
Category 1 1 (2.4) 0 0
Category 2 0 0 0
MV 1 (2.4) 1 (2.4) 2 (14.3)
aMissing value; FEES variable could not be rated
Table 4 Comparison of DSS between patients with clinically relevant
symptoms of anxiety or depression and patients without symptoms of
anxiety or depression using Mann–Whitney U test and comparison of
DSS between male and female patients using the Mann–Whitney
U test
N DSS score
Median (range)
Level of significance
p-value
HADS-D C 8 3 85.0 (18–100) 0.659
HADS-D\ 8 11 57.0 (31–98)
HADS-A C 8 6 76.0 (18–100) 0.662
HADS-A\ 8 8 55.5 (31–98)
Male 7 85.0 (44–100) 0.017a
Female 7 54.0 (18–77)
DSS Dysphagia Severity Score, HADS-D Depression subscale of the
Hospital Anxiety and Depression Scale, HADS-A Anxiety subscale of
the Hospital Anxiety and Depression Scale
aStatistically significant
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affective conditions in more than 40% of the cases. Four of
the participants (28.5%) had already been diagnosed with a
psychiatric condition (psychotic depression, panic disorder,
pervasive developmental disorder—not otherwise speci-
fied, cluster B personality disorder). The patient with
cluster B personality disorder showed clinically relevant
symptoms of anxiety and depression, and the patient with
panic disorder exhibited clinically relevant symptoms of
anxiety. In these patients, MUNOD and affective symp-
toms are likely to be part of their psychiatric disorder.
The DSS scores were not significantly different between
patients with and without clinically relevant affective
symptoms. Apparently, clinically relevant symptoms of
anxiety and depression are not related to the severity of
MUNOD symptoms. A psychological screening question-
naire, like the HADS, is a simple tool for the preliminary
assessment of the affective state of a patient. However, the
expertise of a psychiatrist is essential to a definitive diag-
nosis and treatment of any psychiatric condition, including
phagophobia or other anxiety disorders, and depression. It
might be helpful to draw upon the patient’s psychiatric
history and to involve his or her own psychiatrist when
preparing a multidisciplinary treatment strategy. Involve-
ment of a psychiatrist would obviously be necessary.
However, the patient must be willing to cooperate and
accept that a psychiatric problem might be the cause of the
swallowing problems. In this study, only four patients
could be convinced to visit a psychiatrist after visiting the
outpatient clinic for dysphagia. Following referral to the
psychiatrist, one patient was diagnosed with an anxiety
disorder and one patient was diagnosed with an identity
disorder. Two of the referred patients were already known
with a psychiatric disorder (panic disorder and psychotic
depression), see Table 1. Early recognition of MUNOD
and a motivational trajectory towards integrated care are
necessary to develop effective treatment strategies, to
reduce health care consumption and health care costs, to
decrease the risk of iatrogenic damage arising from con-
tinuous diagnostic intervention, and to prevent frustration
in the interaction between physician and patient [11].
Almost all of the participants had already consulted mul-
tiple specialists or had made recurrent visits to outpatient
clinics all over the Netherlands. Consultation of a psychi-
atrist must be considered as an early option in the diag-
nostic strategy of MUNOD instead of the ‘last resort’ after
unsuccessful treatment. Diagnosis and treatment of an
underlying psychiatric disease may improve the swallow-
ing problems. It is important to realize that affective
symptoms are frequently present in patients with MUNOD.
Assuming a bidirectional pathway between brain and body,
MUNOD could be understood as a symptom of physical
distress or part of an alarm falsification and defense reac-
tion as seen in other functional syndromes. In patients with
prolonged dysphagic complaints, with no indication of a
somatic disease or abnormality, psychiatric conditions
must be considered as a possible cause of OD. Validated
psychological screening questionnaires could be helpful in
the detection of affective conditions but also of other
psychiatric conditions. Involvement of a psychiatrist and/or
psychologist is recommended.
Limitations of the Study
This investigation has some limitations. First, since
MUNOD is a rare condition, the number of patients
included in the study is small, so only a limited statistical
analysis could be performed. Second, the HADS ques-
tionnaire was used for screening of anxiety and depression
symptoms. Possibly, a different screening tool or multiple
screening tools would have led to different results. Third,
three of the participants were taking psychiatric medication
(see Table 1), which could have a negative effect on
swallowing [32, 33]. Furthermore, the use of psychiatric
medication could have led to an underestimation of the
HADS scores. Furthermore, this investigation used a cross-
sectional study design and was not intended as a therapy-
effect study; the effect of different treatment options could
be examined in future research, which could also specify
treatment strategies in patients with MUNOD and psychi-
atric comorbidity.
Conclusion
MUNOD is a rare condition that is difficult to diagnose.
We hope to help dysphagia caregivers by sharing our
results and experiences. Patients deserve a professional
approach, particularly because their diagnostic trajectory
has often been long and inconclusive. Affective symptoms
are common in these patients. MUNOD could be a symp-
tom of a psychiatric condition or part of the alarm falsifi-
cation defense system, suggesting that physical symptoms
and affective disorders are stress-related and a response to
earlier threats. Consultation of a psychiatrist for patients
with MUNOD is recommended as part of a pathway toward
multidisciplinary integrated care.
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